Introducing ACIST AT X65 Exciting Advance: Now you can see the dicrotic notch in greater detail with our new patient kit. Results based on bench testing in a 4 French catheter with saline in the patient tubing and contrast in the catheter. Actual results may vary.3 WATCH THE VIDEO LEARN MORE COVID-19 Resources See how COVID-19 affects kidney health, receive guidance on how to clean our products and our response to the pandemic. LEARN MORE Upcoming Events Join ACIST for upcoming events. LEARN MORE Why ACIST? ACIST Medical Systems provides diagnostic technologies that deliver the power to visualize, assess and improve patient treatment. WATCH VIDEO Your cath lab knowledge catalyst In the cath lab, ACIST gives you what you need to know. Reducing contrast volume For interventional cardiologists who want to manage contrast delivery and minimize risk of contrast-induced acute kidney injury (CI-AKI), ACIST CVi™ delivers the power to control and protect. CVI Optimizing interventions ACIST HDi® provides you the power to see with clarity, for optimizing PCI through intravascular imaging. HDI Complexity, simplified ACIST RXi® and ACIST RXi® Mini™ simplify physiological assessment of complex coronary artery disease. The Navvus® MicroCatheters give you the freedom to quickly and easily assess FFR. RXI SEE OUR PRODUCTS ACIST CVi™ knowledge leadership An expert physician’s perspective on the ACIST CVi™ Contrast Delivery System: Dr. Mark Rothenberg, MD, FACC VIEW FULL INTERVIEW 30+ million Cases performed with CVi 3 views Experience three imaging modes with HDi 0.014" guidewire Use your guidewire of choice with RXi and the Navvus® MicroCatheters. Investing in clinician education ACIST provides a variety of clinical education materials, including clinical research, continuing education webinars, videos, instructional materials and more. RESOURCES FOR PROFESSIONALS TRAINING PROGRAMS Thinking ahead with our physician training Help us determine what future physician training programs should be. SHARE YOUR THOUGHTS News ACIST in the news. ACIST NEWS Articles Read our latest article. ACIST ARTICLES Citations Arturo Cesaro, Felice Gragnano et al; Fractional assessment of coronary stenosis; an overview of available techniques. 2018 July 11, rultao Zhang et al; Meta analysis of Diagnostic Performance of contrast Fractional Flow Reserve versus Quantitative Flow Ration for Functional Assessment of Coronary Stenoses Journal of Interventional Cardiology; 1155/2020/732150 Westra J, Andersen BK et al; Diagnostic performance of in-procedure angiography-derive Quantitative Flow Reserve compared to pressure-derived Fractional Flow Reserve: The FAVOR II Europe-Japan Study J Am Heart Assoc 2018 Data on file. TR-11392R. Based on an amplitude increase of 1.56mmHg and a significant p-value of 0.01 as compared to AT P65. * economic value based on the reduced cost of QFR compared to conventional FFR and the respective cost of administration of hyperemic agent (adenosine) and additional invasive procedural resources ** Reduced side effect profile when compared to FFR with adenosine induced hyperemia ACIST Medical Systems, Inc. is in a distribution partnership with Medis Medical Imaging to comarket QFR® in North America. ABOUT PRODUCTS MEDICAL EDUCATION CONTACT CAREERS ACIST SYMBOL GLOSSARY PART OF THE BRACCO GROUP PRIVACY POLICY TERMS OF USE © 2021 ACIST Medical Systems. All rights reserved.